Objective To investigate the expression profile of microRNA (miRNA) in umbilical cord blood
from infants with hypoxic ischemic encephalopathy (HIE). Study design Full-term infants with …

Introduction: Perinatal asphyxia is a leading cause of neonatal death. Up to one-third of
asphyxiated neonates suffer from hypoxic-ischaemic encephalopathy (HIE) with substantial …

Hypoxic ischemic encephalopathy (HIE) is the most frequent cause of acquired infant brain
injury. Early, clinically relevant biomarkers are required to allow timely application of …

Importance Neonatal hypoxic-ischemic encephalopathy (HIE) remains a significant cause of
neurologic disability. Identifying infants suitable for therapeutic hypothermia (TH) within a …

Background: The potential of microRNAs (miRNAs) as bedside biomarkers in selecting
newborns with hypoxic-ischemic encephalopathy (HIE) for neuroprotection has yet to be …

Neonatal hypoxic–ischemic brain injury (HIBI) is a devastating injury resulting from impaired
blood flow and oxygen delivery to the brain at or around the time of birth. Despite the use of …

Background: There is a lack of reliable biomarkers that can identify and grade acute hypoxic-
ischemic encephalopathy in newborns. MicroRNAs (miRNA) are short, non-coding strands …

Neonates can develop hypoxic-ischaemic encephalopathy (HIE) due to lack of blood supply
or oxygen, resulting in a major cause of death and disability among term newborns …

Objective This study is to investigate the role of microRNA (miR)-30b in the pathogenesis of
hypoxic-ischemic encephalopathy (HIE) in neonates. Methods Totally 26 cases of neonatal …

Neonatal Encephalopathy (NE) is a major cause of lifelong disability and neurological
complications in affected infants. Identifying novel diagnostic biomarkers in this population …